International trends and patterns of primary liver cancer

International Journal of Cancer - Tập 94 Số 2 - Trang 290-296 - 2001
Katherine A. McGlynn1,2, Lilian Tsao1, Ann W. Hsing1, Susan S. Devesa1, Joseph F. Fraumeni1
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
2Fax: +301-402-0916

Tóm tắt

Từ khóa


Tài liệu tham khảo

Parkin, 1999, Int J Cancer, 80, 827, 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P

Pisani, 1999, Int J Cancer, 83, 18, 10.1002/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M

Jin, 1999, Int J Cancer, 83, 435, 10.1002/(SICI)1097-0215(19991112)83:4<435::AID-IJC1>3.0.CO;2-J

Taylor-Robinson, 1997, Lancet, 350, 1142, 10.1016/S0140-6736(05)63789-0

Deuffic, 1998, Lancet, 351, 214, 10.1016/S0140-6736(05)78179-4

El-Serag, 1999, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001

et al. Cancer incidence in five continents, Vol VII. Lyon: IARC Scientific Publications No. 143, International Agency for Research on Cancer, 1997.

et al. Cancer incidence in five continents, Vol V. Lyon: IARC Scientific Publications No. 88, International Agency for Research on Cancer, 1987.

et al. Cancer incidence in five continents, Vol VI. Lyon: IARC Scientific Publications No. 120, International Agency for Research on Cancer, 1992.

WHO. International classification of diseases, 8th revision. Geneva: WHO, 1969.

WHO. International classification of diseases, 9th revision. Geneva: WHO, 1979.

NCI. SEER*Stat 3.0: SEER cancer incidence public-use database, 1973-97. 2000.

Devesa, 1995, Am J Epidemiol, 141, 300, 10.1093/aje/141.4.300

Vatanasapt, 1995, Cancer Epidemiol Biomarker Prev, 4, 475

Kullavanijaya, 1999, Southeast Asian J Trop Med Public Health, 30, 96

Liver Cancer. In: eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996. 772-93

Conio, 2001, Crit Rev Oncol Hematol, 37, 127, 10.1016/S1040-8428(00)00108-6

Ahrendt, 1999, J Gastrointest Surg, 3, 357, 10.1016/S1091-255X(99)80051-1

La Vecchia, 1994, Ann Epidemiol, 4, 480, 10.1016/1047-2797(94)90009-4

El-Serag, 2000, Arch Intern Med, 160, 3227, 10.1001/archinte.160.21.3227

La Vecchia, 2000, Eur J Cancer, 36, 909, 10.1016/S0959-8049(00)00052-6

Nomura, 1996, J Infect Dis, 173, 1474, 10.1093/infdis/173.6.1474

WHO. Global status of hepatitis B immunization policy as of March, 2000. Available on the internet at http://www.who.int/vaccines-surveillance/graphics/htmls/hepb.htm.

Chang, 1997, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602

Chen, 1996, JAMA, 276, 906, 10.1001/jama.1996.03540110060032

WHO. Geographic pattern of hepatitis B prevalence, 1997. Available on the internet at http://www.who.int/vaccines-surveillance/graphics/htmls/hepbprev.htm.

Qian, 1994, Cancer Epidemiol Biomarker Prev, 3, 3

McGlynn, 1995, Proc Natl Acad Sci USA, 92, 2384, 10.1073/pnas.92.6.2384

Sun, 1999, Hepatology, 30, 379, 10.1002/hep.510300204

Yu, 1998, J Toxicol Sci, 23, 143, 10.2131/jts.23.SupplementII_143

Hitzfield, 2000, Environ Health Perspect, 108, 113, 10.1289/ehp.00108s1113

Ling, 2000, Schriftenr Ver Wasser Boden Lufthyg, 105, 43

Frank, 2000, Lancet, 355, 887, 10.1016/S0140-6736(99)06527-7

Alter, 1999, Am J Med, 197, 16s, 10.1016/S0002-9343(99)00375-7

Williams, 1999, Am J Med, 107, 2s, 10.1016/S0002-9343(99)00373-3

WHO. Hepatitis C: global prevalence (update). Available on the internet at http://www.who.int/emc/diseases/hepatiti/index.html.

Nishioka, 1991, Cancer, 67, 429, 10.1002/1097-0142(19910115)67:2<429::AID-CNCR2820670218>3.0.CO;2-#

Tomimatsu, 1993, Cancer, 72, 683, 10.1002/1097-0142(19930801)72:3<683::AID-CNCR2820720310>3.0.CO;2-C

Tanaka, 1994, Cancer Causes Control, 5, 61, 10.1007/BF01830727

Abe, 1998, Hepatology, 28, 568, 10.1002/hep.510280239

Okuda, 2000, J Hepatol, 32, 225, 10.1016/S0168-8278(00)80428-6

Colombo, 1991, Dig Dis Sci, 36, 1130, 10.1007/BF01297459

Stroffolini, 1998, J Hepatol, 29, 944, 10.1016/S0168-8278(98)80122-0

Brechot, 1998, J Hepatol, 29, 173, 10.1016/S0168-8278(98)80001-9

Tagger, 1999, Int J Cancer, 81, 695, 10.1002/(SICI)1097-0215(19990531)81:5<695::AID-IJC4>3.0.CO;2-W

Nalpas, 1991, J Hepatol, 12, 70, 10.1016/0168-8278(91)90912-U

Bruix, 1989, Lancet, 2, 1004, 10.1016/S0140-6736(89)91015-5

Caselmann, 1996, J Hepatol, 24, 61

Petry, 1997, Z Gastroenterol, 35, 1059

Peters, 1994, Z Gastroenterol, 32, 1146

Kaczynski, 1996, Scan J Gastroenterol, 31, 809, 10.3109/00365529609010357

Widell, 2000, Scand J Infect Dis, 32, 147, 10.1080/003655400750045240

Tao, 1992, Chin Med J, 105, 209

Yuan, 1996, Br J Cancer, 74, 491, 10.1038/bjc.1996.389

Cao, 1998, J Gastroenterol Hepatol, 13, 1241, 10.1111/j.1440-1746.1998.tb00612.x

Yuan, 1999, Cancer, 86, 936, 10.1002/(SICI)1097-0142(19990915)86:6<936::AID-CNCR7>3.0.CO;2-T

Yap, 1991, Southeast Asian J Trop Med Public Health, 22, 581

Khin, 1996, Singapore Med J, 37, 492

Tangkijvanich, 1999, J Gastroenterol, 34, 227, 10.1007/s005350050248

Di Bisceglie, 1994, J Clin Gastroenterol, 19, 222, 10.1097/00004836-199410000-00011

Hwang, 1996, Gastroenterol Hepatol, 11, 949, 10.1111/j.1440-1746.1996.tb00279.x

Seeff, 2000, Ann Intern Med, 132, 105, 10.7326/0003-4819-132-2-200001180-00003

Alter, 1999, N Engl J Med, 341, 556, 10.1056/NEJM199908193410802

Chiaramonte, 1991, Ital J Gastroenterol, 23, 555

Chiba, 1996, Am J Gastroenterology, 91, 1195

Niederau, 1998, Hepatology, 28, 2687, 10.1002/hep.510280632

Seeff, 1999, Am J Med, 107, 10s, 10.1016/S0002-9343(99)00374-5

Schiff, 1999, Am J Med, 107, 95s, 10.1016/S0002-9343(99)00393-9

Seeff, 1998, Hepatology, 28, 406a, 10.1002/hep.510280636

Poynard, 1997, Lancet, 349, 825, 10.1016/S0140-6736(96)07642-8

Khan, 2000, Hepatol, 31, 513, 10.1002/hep.510310236

Linnen, 1996, Science, 271, 505, 10.1126/science.271.5248.505

Nishizawa, 1997, Biochem Biophysic Research Comm, 241, 92, 10.1006/bbrc.1997.7765

Muller, 1997, J Viral Hepat, 4, 411, 10.1046/j.1365-2893.1997.00071.x

Tagger, 1997, Hepatology, 26, 1653

Hollingsworth, 1998, J Viral Hepat, 5, 165, 10.1046/j.1365-2893.1998.00102.x

Lightfoot, 1997, Hepatology, 26, 740, 10.1002/hep.510260328

Chiesa, 2000, Cancer Epidemiol Biomarker Prev, 9, 213

Kato, 1999, J Hepatol, 31, 221, 10.1016/S0168-8278(99)80217-7

Shimizu, 1999, Nippon Rinsho, 57, 1381

Tagger, 1999, Hepatology, 30, 294, 10.1002/hep.510300115

Skelton, 2000, J Viral Hepat, 7, 230, 10.1046/j.1365-2893.2000.00223.x

Yotsuyanagi, 2000, J Infect Dis, 181, 1920, 10.1086/315512

Pineau, 2000, J Infect Dis, 181, 1138, 10.1086/315321

WHO. International classification of diseases for oncology, 2nd edition. Geneva: WHO, 1990.